Mismatch Negativity as an Index of Auditory Short-Term Plasticity: Associations with Cortisol,Inflammation,and Gray Matter Volume in Youth at Clinical High Risk for Psychosis
Restricted accessResearch articleFirst published online January, 2025
Mismatch Negativity as an Index of Auditory Short-Term Plasticity: Associations with Cortisol,Inflammation,and Gray Matter Volume in Youth at Clinical High Risk for Psychosis
Mismatch negativity (MMN) event-related potential (ERP) component reduction, indexing N-methyl-D-aspartate receptor (NMDAR)-dependent auditory echoic memory and short-term plasticity, is a well-established biomarker of schizophrenia that is sensitive to psychosis risk among individuals at clinical high-risk (CHR-P). Based on the NMDAR-hypofunction model of schizophrenia, NMDAR-dependent plasticity is predicted to contribute to aberrant neurodevelopmental processes involved in the pathogenesis of schizophrenia during late adolescence or young adulthood, including gray matter loss. Moreover, stress and inflammation disrupt plasticity. Therefore, using data collected during the 8-center North American Prodrome Longitudinal Study (NAPLS-2), we explored relationships between MMN amplitudes and salivary cortisol, gray matter volumes, and inflammatory cytokines. Participants included 303 CHR-P individuals with baseline electroencephalography (EEG) data recorded during an MMN paradigm as well as structural magnetic resonance imaging (MRI) and salivary cortisol, of which a subsample (n = 57) also completed blood draws. More deficient MMN amplitudes were associated with greater salivary cortisol and pro-inflammatory cytokine levels in future CHR-Converters, but not among those who did not convert to psychosis within the next two years. More deficient MMN amplitude was also associated with smaller total gray matter volume across participants regardless of future clinical outcomes, and with subcortical gray matter volumes among future CHR-Converters only. These findings are consistent with the theory that deficient NMDAR-dependent plasticity results in an overabundance of weak synapses that are subject to over-pruning during psychosis onset, contributing to gray matter loss. Further, MMN plasticity mechanisms may interact with stress, cortisol, and neuroinflammatory processes, representing a proximal influence of psychosis.
EricksonMARuffleAGoldJM. A meta-analysis of mismatch negativity in schizophrenia: From clinical risk to disease specificity and progression. Biol Psychiatry.Aug 2016;79(12):980–987. doi:https://doi.org/10.1016/j.biopsych.2015.08.025
3.
BaldewegTKlugmanAGruzelierJHirschSR. Mismatch negativity potentials and cognitive impairment in schizophrenia. Schizophr Res.Aug 2004;69(2-3):203–217. doi:https://doi.org/10.1016/j.schres.2003.09.009
4.
HermensDFWardPBHodgeMAKaurMNaismithSLHickieIB. Impaired MMN/P3a complex in first-episode psychosis: Cognitive and psychosocial associations. Prog Neuropsychopharmacol Biol Psychiatry. Aug 16 2010;34(6):822–829. doi:https://doi.org/10.1016/j.pnpbp.2010.03.019
5.
KiangMLightGAPrughJCoulsonSBraffDLKutasM. Cognitive, neurophysiological, and functional correlates of proverb interpretation abnormalities in schizophrenia. J Int Neuropsychol Soc. Jul 2007;13(4):653–663. doi:https://doi.org/10.1017/S1355617707070816
6.
ThomasMLGreenMFHellemannG, et al.Modeling deficits from early auditory information processing to psychosocial functioning in schizophrenia. JAMA Psychiatry. Jan 1 2017;74(1):37–46. doi:https://doi.org/10.1001/jamapsychiatry.2016.2980
7.
LightGABraffDL. Mismatch negativity deficits are associated with poor functioning in schizophrenia patients. Arch Gen Psychiatry.2005;62(2):127. doi:https://doi.org/10.1001/archpsyc.62.2.127
8.
HamiltonHKPerezVBFordJMRoachBJJaegerJMathalonDH. Mismatch negativity but not P300 is associated with functional disability in schizophrenia. Schizophr Bull. Apr 6 2018;44(3):492–504. doi:https://doi.org/10.1093/schbul/sbx104
9.
NäätänenRTederWAlhoKLavikainenJ. Auditory attention and selective input modulation: A topographical ERP study. NeuroReport. Jun 01 1992;3(6):493. doi:https://doi.org/10.1097/00001756-199206000-00009
10.
NäätänenRJacobsenTWinklerI. Memory-based or afferent processes in mismatch negativity (MMN): A review of the evidence. Psychophysiology. Jan 01 2005;42(1):25–32. doi:https://doi.org/10.1111/j.1469-8986.2005.00256.x
11.
SussmanESheridanKKreuzerJWinklerI. Representation of the standard: Stimulus context effects on the process generating the mismatch negativity component of event-related brain potentials. Psychophysiology. May 2003;40(3):465–471. doi:https://doi.org/10.1111/1469-8986.00048
MathalonDHFordJM. Divergent approaches converge on frontal lobe dysfunction in schizophrenia. Am J Psychiatry.Aug 2008;165(8):944–948. doi:https://doi.org/10.1176/appi.ajp.2008.08050735
14.
KrystalJHKarperLPSeibylJP, et al.Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Arch Gen Psychiatry.Mar 01 1994;51(3):199. doi:https://doi.org/10.1001/archpsyc.1994.03950030035004
15.
RosburgTKreitschmann-AndermahrI. The effects of ketamine on the mismatch negativity (MMN) in humans - A meta-analysis. Clin Neurophysiol. Feb 2016;127(2):1387–1394. doi:https://doi.org/10.1016/j.clinph.2015.10.062
16.
JavittDCShelleyARitterW. Associated deficits in mismatch negativity generation and tone matching in schizophrenia. Clin Neurophysiol. Oct 2000;111(10):1733–1737. doi:https://doi.org/10.1016/s1388-2457(00)00377-1
17.
JavittDCLeeMKantrowitzJTMartinezA. Mismatch negativity as a biomarker of theta band oscillatory dysfunction in schizophrenia. Schizophr Res. Jan 2018;191:51–60. doi:https://doi.org/10.1016/j.schres.2017.06.023
18.
JavittDC. Intracortical mechanisms of mismatch negativity dysfunction in schizophrenia. Audiol Neurootol. May-Aug 2000;5(3-4):207–215. doi:https://doi.org/10.1159/000013882
19.
KrystalJHAnandAMoghaddamB. Effects of NMDA receptor antagonists: Implications for the pathophysiology of schizophrenia. Arch Gen Psychiatry.Jul 01 2002;59(7):663–664. doi:https://doi.org/10.1001/archpsyc.57.3.270
20.
MoghaddamBJavittD. From revolution to evolution: The glutamate hypothesis of schizophrenia and its implication for treatment. Neuropsychopharmacology. 2012;37(1):4–15. doi:https://doi.org/10.1038/npp.2011.181
21.
MoghaddamBKrystalJH. Capturing the angel in “angel dust”: Twenty years of translational neuroscience studies of NMDA receptor antagonists in animals and humans. Schizophr Bull.Sep 01 2012;38(5):942–949. doi:https://doi.org/10.1093/schbul/sbs075
22.
CoyleJTTsaiGGoffD. Converging evidence of NMDA receptor hypofunction in the pathophysiology of Schizophrenia. Ann N Y Acad Sci. Nov 2003;1003:318-327. doi:https://doi.org/10.1196/annals.1300.020
23.
HaighSMCoffmanBASalisburyDF. Mismatch negativity in first-episode schizophrenia: A meta-analysis. Clin EEG Neurosci. Jan 2017;48(1):3–10. doi:https://doi.org/10.1177/1550059416645980
24.
FisherDJCampbellDJAbrielSCEllsEMLRudolphEDTibboPG. Auditory mismatch negativity and P300a elicited by the “optimal” multi-feature paradigm in early schizophrenia. Clin EEG Neurosci. Jul 2018;49(4):238–247. doi:https://doi.org/10.1177/1550059418761459
25.
FisherDJRudolphEDEllsEMLKnottVJLabelleATibboPG. Mismatch negativity-indexed auditory change detection of speech sounds in early and chronic schizophrenia. Psychiatry Res Neuroimaging. May 30 2019;287:1–9. doi:https://doi.org/10.1016/j.pscychresns.2019.03.010
26.
SalisburyDFShentonMEGriggsCBBonner-JacksonAMcCarleyRW. Mismatch negativity in chronic schizophrenia and first-episode schizophrenia. Arch Gen Psychiatry. Aug 2002;59(8):686–694. doi:https://doi.org/10.1001/archpsyc.59.8.686
27.
MagnoEYeapSThakoreJHGaravanHDe SanctisPFoxeJJ. Are auditory-evoked frequency and duration mismatch negativity deficits endophenotypic for schizophrenia? High-density electrical mapping in clinically unaffected first-degree relatives and first-episode and chronic schizophrenia. Biol Psychiatry. Sep 1 2008;64(5):385–391. doi:https://doi.org/10.1016/j.biopsych.2008.03.019
28.
HamiltonHKRoachBJBachmanPM, et al.Mismatch negativity in response to auditory deviance and risk for future psychosis in youth at clinical high risk for psychosis. JAMA Psychiatry. Aug 1 2022;79(8):780–789. doi:https://doi.org/10.1001/jamapsychiatry.2022.1417
29.
PerezVBWoodsSWRoachBJ, et al.Automatic auditory processing deficits in schizophrenia and clinical high-risk patients: Forecasting psychosis risk with mismatch negativity. Biol Psychiatry. Mar 15 2014;75(6):459–469. doi:https://doi.org/10.1016/j.biopsych.2013.07.038
30.
ShaikhMValmaggiaLBroomeMR, et al.Reduced mismatch negativity predates the onset of psychosis. Schizophr Res. Jan 2012;134(1):42–48. doi:https://doi.org/10.1016/j.schres.2011.09.022
HiguchiYSumiyoshiTSeoTMiyanishiTKawasakiYSuzukiM. Mismatch negativity and cognitive performance for the prediction of psychosis in subjects with at-risk mental state. PLoS One. 2013;8(1):e54080. doi:https://doi.org/10.1371/journal.pone.0054080
33.
AtkinsonRJMichiePTSchallU. Duration mismatch negativity and P3a in first-episode psychosis and individuals at ultra-high risk of psychosis. Biol Psychiatry. Jan 15 2012;71(2):98–104. doi:https://doi.org/10.1016/j.biopsych.2011.08.023
34.
AtkinsonRJFulhamWRMichiePT, et al.Electrophysiological, cognitive and clinical profiles of at-risk mental state: The longitudinal minds in transition (MinT) study. PLoS One. 2017;12(2):e0171657. doi:https://doi.org/10.1371/journal.pone.0171657
35.
BodatschMBrockhaus-DumkeAKlosterkotterJRuhrmannS. Forecasting psychosis by event-related potentials-systematic review and specific meta-analysis. Biol Psychiatry. Jun 01 2015;77(11):951–958. doi:https://doi.org/10.1016/j.biopsych.2014.09.025
GarridoMIKilnerJMKiebelSJStephanKEBaldewegTFristonKJ. Repetition suppression and plasticity in the human brain. Neuroimage. Oct 15 2009;48(1):269–279. doi:https://doi.org/10.1016/j.neuroimage.2009.06.034
38.
GarridoMIKilnerJMStephanKEFristonKJ. The mismatch negativity: A review of underlying mechanisms. Clin Neurophysiol.Mar 2009;120(3):453–463. doi:https://doi.org/10.1016/j.clinph.2008.11.029
39.
BaldewegTWongDStephanKE. Nicotinic modulation of human auditory sensory memory: Evidence from mismatch negativity potentials. EEG Coherence. 2006;59(1):49–58. doi:https://doi.org/10.1016/j.ijpsycho.2005.07.014
40.
BaldewegTHirschSR. Mismatch negativity indexes illness-specific impairments of cortical plasticity in schizophrenia: A comparison with bipolar disorder and Alzheimer's disease. Int J Psychophysiol. Feb 2015;95(2):145–155. doi:https://doi.org/10.1016/j.ijpsycho.2014.03.008
41.
StrelnikovK. Can mismatch negativity be linked to synaptic processes? A glutamatergic approach to deviance detection. Brain Cogn. Dec 2007;65(3):244–251. doi:https://doi.org/10.1016/j.bandc.2007.04.002
42.
BaldewegT. Repetition effects to sounds: Evidence for predictive coding in the auditory system. Trends Cogn Sci. Mar 2006;10(3):93–94. doi:https://doi.org/10.1016/j.tics.2006.01.010
43.
HaenschelCVernonDJDwivediPGruzelierJHBaldewegT. Event-related brain potential correlates of human auditory sensory memory-trace formation. J Neurosci. Nov 9 2005;25(45):10494–10501. doi:https://doi.org/10.1523/JNEUROSCI.1227-05.2005
44.
SchmidtABachmannRKometerM, et al.Mismatch negativity encoding of prediction errors predicts S-ketamine-induced cognitive impairments. Neuropsychopharmacology. Oct 26 2012;37(4):865–875. doi:https://doi.org/10.1038/npp.2011.261
45.
FryerSLRoachBJHamiltonHK, et al.Deficits in auditory predictive coding in individuals with the psychosis risk syndrome: Prediction of conversion to psychosis. J Abnorm Psychol. Aug 2020;129(6):599–611. doi:https://doi.org/10.1037/abn0000513
SchaferDPLehrmanEKKautzmanAG, et al.Microglia sculpt postnatal neural circuits in an activity and complement-dependent manner. Neuron. May 24 2012;74(4):691–705. doi:https://doi.org/10.1016/j.neuron.2012.03.026
48.
HuttenlocherPR. Synaptic density in human frontal cortex - developmental changes and effects of aging. Brain Res. Mar 16 1979;163(2):195–205. doi:https://doi.org/10.1016/0006-8993(79)90349-4
RakicPBourgeoisJPEckenhoffMFZecevicNGoldman-RakicPS. Concurrent overproduction of synapses in diverse regions of the primate cerebral cortex. Science. Apr 11 1986;232(4747):232–235. doi:https://doi.org/10.1126/science.3952506
51.
FeinbergI. Schizophrenia: Caused by a fault in programmed synaptic elimination during adolescence?J Psychiatr Res. 1982;17(4):319–334. doi:https://doi.org/10.1016/0022-3956(82)90038-3
52.
Schizophrenia Working Group of the Psychiatric Genomics C. Biological insights from 108 schizophrenia-associated genetic loci. Nature. Jul 24 2014;511(7510):421–427. doi:https://doi.org/10.1038/nature13595
53.
SekarABialasARde RiveraH, et al.Schizophrenia risk from complex variation of complement component 4. Nature. Feb 11 2016;530(7589):177–183. doi:https://doi.org/10.1038/nature16549
SelemonLDGoldman-RakicPS. The reduced neuropil hypothesis: A circuit based model of schizophrenia. Biol Psychiatry. Jan 1 1999;45(1):17–25. doi:https://doi.org/10.1016/s0006-3223(98)00281-9
LevittJJBobrowLLuciaDSrinivasanP. A selective review of volumetric and morphometric imaging in schizophrenia. Curr Top Behav Neurosci. 2010;4:243–281. doi:https://doi.org/10.1007/7854_2010_53
60.
ChungYHautKMHeG, et al.Ventricular enlargement and progressive reduction of cortical gray matter are linked in prodromal youth who develop psychosis. Schizophr Res. Nov 2017;189:169–174. doi:https://doi.org/10.1016/j.schres.2017.02.014
61.
CannonTDChungYHeG, et al.Progressive reduction in cortical thickness as psychosis develops: A multisite longitudinal neuroimaging study of youth at elevated clinical risk. Biol Psychiatry. Jan 15 2015;77(2):147–157. doi:https://doi.org/10.1016/j.biopsych.2014.05.023
62.
ChungYCannonTD. Brain imaging during the transition from psychosis prodrome to schizophrenia. J Nerv Ment Dis. May 2015;203(5):336–341. doi:https://doi.org/10.1097/NMD.0000000000000286
63.
DingYOuYPanP, et al.Brain structural abnormalities as potential markers for detecting individuals with ultra-high risk for psychosis: A systematic review and meta-analysis. Schizophr Res. Jul 2019;209:22–31. doi:https://doi.org/10.1016/j.schres.2019.05.015
64.
JalbrzikowskiMHayesRAWoodSJ, et al.Association of structural magnetic resonance imaging measures with psychosis onset in individuals at clinical high risk for developing psychosis: An ENIGMA working group mega-analysis. JAMA Psychiatry. Jul 1 2021;78(7):753–766. doi:https://doi.org/10.1001/jamapsychiatry.2021.0638
MottahedinAArdalanMChumakTRiebeIEkJMallardC. Effect of neuroinflammation on synaptic organization and function in the developing brain: Implications for neurodevelopmental and neurodegenerative disorders. Front Cell Neurosci. 2017;11:190. doi:https://doi.org/10.3389/fncel.2017.00190
67.
HaroonEMillerAHSanacoraG. Inflammation, glutamate, and Glia: A trio of trouble in mood disorders. Neuropsychopharmacology. Jan 2017;42(1):193–215. doi:https://doi.org/10.1038/npp.2016.199
68.
MartinJLFinsterwaldC. Cooperation between BDNF and glutamate in the regulation of synaptic transmission and neuronal development. Commun Integr Biol. Jan 2011;4(1):14–16. doi:https://doi.org/10.4161/cib.4.1.13761
PittengerCDumanRS. Stress, depression, and neuroplasticity: A convergence of mechanisms. Neuropsychopharmacology. Jan 2008;33(1):88–109. doi:https://doi.org/10.1038/sj.npp.1301574
GarciaR. Stress, hippocampal plasticity, and spatial learning. Synapse. Jun 1 2001;40(3):180–183. doi:https://doi.org/10.1002/syn.1040
74.
ShorsTJFoyMRLevineSThompsonRF. Unpredictable and uncontrollable stress impairs neuronal plasticity in the rat hippocampus. Brain Res Bull. May 1990;24(5):663–667. doi:https://doi.org/10.1016/0361-9230(90)90005-k
XuLAnwylRRowanMJ. Behavioural stress facilitates the induction of long-term depression in the hippocampus. Nature. May 29 1997;387(6632):497–500. doi:https://doi.org/10.1038/387497a0
77.
DubrovskyBWilliamsDKraulisI. Effects of corticosterone and 5 alpha-dihydrocorticosterone on brain excitability in the rat. J Neurosci Res. 1985;14(1):117–128. doi:https://doi.org/10.1002/jnr.490140111
78.
PavlidesCWatanabeYMcEwenBS. Effects of glucocorticoids on hippocampal long-term potentiation. Hippocampus. Apr 1993;3(2):183–192. doi:https://doi.org/10.1002/hipo.450030210
79.
DinseHRKattenstrothJCLenzMTegenthoffMWolfOT. The stress hormone cortisol blocks perceptual learning in humans. Psychoneuroendocrinology. Mar 2017;77:63–67. doi:https://doi.org/10.1016/j.psyneuen.2016.12.002
80.
SaleMVRiddingMCNordstromMA. Cortisol inhibits neuroplasticity induction in human motor cortex. J Neurosci. Aug 13 2008;28(33):8285–8293. doi:https://doi.org/10.1523/JNEUROSCI.1963-08.2008
81.
LynchMA. Age-related neuroinflammatory changes negatively impact on neuronal function. Front Aging Neurosci. 2010;1:6. doi:https://doi.org/10.3389/neuro.24.006.2009
82.
MurrayCALynchMA. Evidence that increased hippocampal expression of the cytokine interleukin-1 beta is a common trigger for age- and stress-induced impairments in long-term potentiation. J Neurosci. Apr 15 1998;18(8):2974–2981. doi:https://doi.org/10.1523/JNEUROSCI.18-08-02974.1998
83.
PerryVH. The influence of systemic inflammation on inflammation in the brain: Implications for chronic neurodegenerative disease. Brain Behav Immun. Sep 2004;18(5):407–413. doi:https://doi.org/10.1016/j.bbi.2004.01.004
84.
LiuXWuZHayashiYNakanishiH. Age-dependent neuroinflammatory responses and deficits in long-term potentiation in the hippocampus during systemic inflammation. Neuroscience. Aug 2 2012;216:133–142. doi:https://doi.org/10.1016/j.neuroscience.2012.04.050
KannOAlmouhannaFChausseB. Interferon gamma: A master cytokine in microglia-mediated neural network dysfunction and neurodegeneration. Trends Neurosci. Dec 2022;45(12):913–927. doi:https://doi.org/10.1016/j.tins.2022.10.007
MonteiroSFerreiraFMPintoV, et al.Absence of IFNgamma promotes hippocampal plasticity and enhances cognitive performance. Transl Psychiatry. Jan 5 2016;6(1):e707. doi:https://doi.org/10.1038/tp.2015.194
89.
LitteljohnDNelsonEHayleyS. IFN-gamma differentially modulates memory-related processes under basal and chronic stressor conditions. Front Cell Neurosci. 2014;8:391. doi:https://doi.org/10.3389/fncel.2014.00391
90.
MillerBJBuckleyPSeaboltWMellorAKirkpatrickB. Meta-analysis of cytokine alterations in schizophrenia: Clinical status and antipsychotic effects. Biol Psychiatry. Oct 1 2011;70(7):663–671. doi:https://doi.org/10.1016/j.biopsych.2011.04.013
91.
BechterKReiberHHerzogSFuchsDTumaniHMaxeinerHG. Cerebrospinal fluid analysis in affective and schizophrenic spectrum disorders: Identification of subgroups with immune responses and blood-CSF barrier dysfunction. J Psychiatr Res. Apr 2010;44(5):321–330. doi:https://doi.org/10.1016/j.jpsychires.2009.08.008
92.
MaxeinerHGRojewskiMTSchmittATumaniHBechterKSchmittM. Flow cytometric analysis of T cell subsets in paired samples of cerebrospinal fluid and peripheral blood from patients with neurological and psychiatric disorders. Brain Behav Immun. Jan 2009;23(1):134–142. doi:https://doi.org/10.1016/j.bbi.2008.08.003
93.
LeeEEHongSMartinASEylerLTJesteDV. Inflammation in schizophrenia: Cytokine levels and their relationships to demographic and clinical variables. Am J Geriatr Psychiatry. Jan 2017;25(1):50–61. doi:https://doi.org/10.1016/j.jagp.2016.09.009
94.
PerkinsDOJeffriesCDAddingtonJ, et al.Towards a psychosis risk blood diagnostic for persons experiencing high-risk symptoms: Preliminary results from the NAPLS project. Schizophr Bull. Mar 2015;41(2):419–428. doi:https://doi.org/10.1093/schbul/sbu099
95.
HalsteadSSiskindDAmftM, et al.Alteration patterns of peripheral concentrations of cytokines and associated inflammatory proteins in acute and chronic stages of schizophrenia: A systematic review and network meta-analysis. Lancet Psychiatry. Apr 2023;10(4):260–271. doi:https://doi.org/10.1016/S2215-0366(23)00025-1
96.
GoldsmithDRRapaportMHMillerBJ. A meta-analysis of blood cytokine network alterations in psychiatric patients: Comparisons between schizophrenia, bipolar disorder and depression. Mol Psychiatry. Dec 2016;21(12):1696–1709. doi:https://doi.org/10.1038/mp.2016.3
97.
ParkSMillerBJ. Meta-analysis of cytokine and C-reactive protein levels in high-risk psychosis. Schizophr Res. Dec 2020;226:5–12. doi:https://doi.org/10.1016/j.schres.2019.03.012
98.
MisiakBPruessnerMSamochowiecJWisniewskiMReginiaAStanczykiewiczB. A meta-analysis of blood and salivary cortisol levels in first-episode psychosis and high-risk individuals. Front Neuroendocrinol. Jul 2021;62:100930. doi:https://doi.org/10.1016/j.yfrne.2021.100930
99.
McGlashanTHWalshBCWoodsSW. The Psychosis-Risk Syndrome: Handbook for Diagnosis and Follow-up. Oxford University Press; 2010.
100.
MillerTJMcGlashanTHRosenJL, et al.Prodromal assessment with the structured interview for prodromal syndromes and the scale of prodromal symptoms: Predictive validity, interrater reliability, and training to reliability. Schizophr Bull. 2003;29(4):703–715.
101.
AddingtonJCadenheadKSCornblattBA, et al.North American prodrome longitudinal study (NAPLS 2): Overview and recruitment. Schizophr Res. Dec 2012;142(1-3):77–82. doi:https://doi.org/10.1016/j.schres.2012.09.012
102.
AddingtonJLiuLBuchyL, et al.North American prodrome longitudinal study (NAPLS 2): The prodromal symptoms. J Nerv Ment Dis. May 2015;203(5):328–335. doi:https://doi.org/10.1097/NMD.0000000000000290
103.
RoachBJCarrionREHamiltonHK, et al.Reliability of mismatch negativity event-related potentials in a multisite, traveling subjects study. Clin Neurophysiol. Dec 2020;131(12):2899–2909. doi:https://doi.org/10.1016/j.clinph.2020.09.027
104.
GrattonGColesMDonchinE. A new method for off-line removal of ocular artifact. Electroencephalogr Clin Neurophysiol.1983;55(4):468–484. doi:https://doi.org/10.1016/0013-4694(83)90135-9
DelormeAMakeigS. EEGLAB: An open source toolbox for analysis of single-trial EEG dynamics including independent component analysis. J Neurosci Methods. Mar 15 2004;134(1):9–21. doi:https://doi.org/10.1016/j.jneumeth.2003.10.009
HamiltonHKRoachBJBachmanPM, et al.Association Between P300 Responses to Auditory Oddball Stimuli and Clinical Outcomes in the Psychosis Risk Syndrome. JAMA Psychiatry. Aug 7 2019. doi:https://doi.org/10.1001/jamapsychiatry.2019.2135
109.
HamiltonHKWoodsSWRoachBJ, et al.Auditory and visual oddball stimulus processing deficits in schizophrenia and the psychosis risk syndrome: Forecasting psychosis risk with P300. Schizophr Bull. Sep 11 2019;45(5):1068–1080. doi:https://doi.org/10.1093/schbul/sby167
110.
RoachBJHamiltonHKBachmanP, et al.Stability of mismatch negativity event-related potentials in a multisite study. Int J Methods Psychiatr Res. Jun 2020;29(2):e1819. doi:https://doi.org/10.1002/mpr.1819
111.
LiIChiouHHShenPS. Correlations between cortisol level and internalizing disposition of young children are increased by selecting optimal sampling times and aggregating data. Dev Psychobiol. Sep 2007;49(6):633–639. doi:https://doi.org/10.1002/dev.20239
112.
WalkerEFTrotmanHDPearceBD, et al.Cortisol levels and risk for psychosis: Initial findings from the north American prodrome longitudinal study. Biol Psychiatry. Sep 15 2013;74(6):410–417. doi:https://doi.org/10.1016/j.biopsych.2013.02.016
113.
CullenAEAddingtonJBeardenCE, et al.Stressor-Cortisol concordance among individuals at clinical high-risk for psychosis: Novel findings from the NAPLS cohort. Psychoneuroendocrinology. May 2020;115:104649. doi:https://doi.org/10.1016/j.psyneuen.2020.104649
114.
CannonTDSunFMcEwenSJ, et al.Reliability of neuroanatomical measurements in a multisite longitudinal study of youth at risk for psychosis. Hum Brain Mapp. May 2014;35(5):2424–2434. doi:https://doi.org/10.1002/hbm.22338
115.
DaleAMFischlBSerenoMI. Cortical surface-based analysis. I. Segmentation and surface reconstruction. Neuroimage. Feb 1999;9(2):179–194. doi:https://doi.org/10.1006/nimg.1998.0395
116.
FischlBvan der KouweADestrieuxC, et al.Automatically parcellating the human cerebral cortex. Cereb Cortex. Jan 2004;14(1):11–22. doi:https://doi.org/10.1093/cercor/bhg087
117.
DesikanRSSegonneFFischlB, et al.An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest. Neuroimage. Jul 1 2006;31(3):968–980. doi:https://doi.org/10.1016/j.neuroimage.2006.01.021
118.
GoldsmithDRHaroonEMillerAH, et al.Association of baseline inflammatory markers and the development of negative symptoms in individuals at clinical high risk for psychosis. Brain Behav Immun. Feb 2019;76:268–274. doi:https://doi.org/10.1016/j.bbi.2018.11.315
119.
NagaiTKiriharaKTadaM, et al.Reduced mismatch negativity is associated with increased plasma level of glutamate in first-episode psychosis. Sci Rep. May 23 2017;7(1):2258. doi:https://doi.org/10.1038/s41598-017-02267-1
120.
KoshiyamaDKiriharaKTadaM, et al.Duration and frequency mismatch negativity shows no progressive reduction in early stages of psychosis. Schizophr Res. Dec 2017;190:32–38. doi:https://doi.org/10.1016/j.schres.2017.03.015
121.
TrotmanHDHoltzmanCWWalkerEF, et al.Stress exposure and sensitivity in the clinical high-risk syndrome: Initial findings from the north American prodrome longitudinal study (NAPLS). Schizophr Res. Dec 2014;160(1-3):104–109. doi:https://doi.org/10.1016/j.schres.2014.09.017
122.
AberizkKCollinsMAAddingtonJ, et al.Life event stress and reduced cortical thickness in youth at clinical high risk for psychosis and healthy control subjects. Biol Psychiatry Cogn Neurosci Neuroimaging. 2022;7(2):171–179. doi:https://doi.org/10.1016/j.bpsc.2021.04.011
123.
AberizkKAddingtonJMBeardenCE, et al.Relations of lifetime perceived stress and basal cortisol with hippocampal volume among healthy adolescents and those at clinical high risk for psychosis: A structural equation modeling approach. Biol Psychiatry. 2024;96(5):401–411. doi:https://doi.org/10.1016/j.biopsych.2023.11.027
124.
van ErpTGHibarDPRasmussenJM, et al.Subcortical brain volume abnormalities in 2028 individuals with schizophrenia and 2540 healthy controls via the ENIGMA consortium. Mol Psychiatry. Apr 2016;21(4):585. doi:https://doi.org/10.1038/mp.2015.118
125.
van ErpTGMWaltonEHibarDP, et al.Cortical brain abnormalities in 4474 individuals with schizophrenia and 5098 control subjects via the enhancing neuro imaging genetics through meta analysis (ENIGMA) consortium. Biol Psychiatry. Nov 1 2018;84(9):644–654. doi:https://doi.org/10.1016/j.biopsych.2018.04.023
126.
GlahnDCLairdAREllison-WrightI, et al.Meta-analysis of gray matter anomalies in schizophrenia: Application of anatomic likelihood estimation and network analysis. Biol Psychiatry. Nov 1 2008;64(9):774–781. doi:https://doi.org/10.1016/j.biopsych.2008.03.031
127.
ZhangYCattsVSSheedyDMcCrossinTKrilJJShannon WeickertC. Cortical grey matter volume reduction in people with schizophrenia is associated with neuro-inflammation. Transl Psychiatry. Dec 13 2016;6(12):e982. doi:https://doi.org/10.1038/tp.2016.238
McEwenBSNascaCGrayJD. Stress effects on neuronal structure: Hippocampus, amygdala, and prefrontal Cortex. Neuropsychopharmacology. Jan 2016;41(1):3–23. doi:https://doi.org/10.1038/npp.2015.171
130.
CollipDHabetsPMarcelisM, et al.Hippocampal volume as marker of daily life stress sensitivity in psychosis. Psychol Med. Jul 2013;43(7):1377–1387. doi:https://doi.org/10.1017/S003329171200219X
131.
RistanovicIVargasTGDammeKSFMittalVA. Hippocampal subfields, daily stressors, and resting cortisol in individuals at clinical high-risk for psychosis. Psychoneuroendocrinology. Feb 2023;148:105996. doi:https://doi.org/10.1016/j.psyneuen.2022.105996
